Frequently Asked Questions
The market is segmented based on , By Product Type (Single-use, Reusable), Cell (Mammalian Cells, Bacterial Cells, Yeast Cells), Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy), Usage (Lab-Scale Production, Developmental, Pre-clinical and Clinical, Commercial Production, Pilot-Scale Production and Full-Scale Production), Scale (5L-20L, 20L-200L, 200L-1500L and Above 1500L), Material (Glass, Stainless Steel and Single Use), Control Type (Manual and Automated), Suppliers (OEM, System Integrators, EPCs), End User (Research and Development Departments, Research and Development Institutes, CROs, Biopharmaceutical Companies, Biopharmaceutical Manufacturer and CMOs) – Industry Trends and Forecast to 2030.
.
The Global Bioreactors Market size was valued at USD 1327.75 USD Million in 2022.
The Global Bioreactors Market is projected to grow at a CAGR of 7.9% during the forecast period of 2023 to 2030.
The major players operating in the market include Sartorius AG, Thermo Fisher Scientific , General Electric, Eppendorf AG, Merck KGaA, Pall Corporation, ZETA, PIERRE GUERIN, PRaj Hipurity Systems Limited, Bioengineering AG, Infors AG, Solaris Biotechnology Srl., Bbi Biotech, Shanghai Bailun Biotechnology co., PBS Biotech , CerCell A/S, GEA Group Aktiengesellschaft.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
